Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T, Takahashi M, Kitani T, Kinoshita T
Department of Immunoregulation, Osaka University, Japan.
Cell. 1993 May 21;73(4):703-11. doi: 10.1016/0092-8674(93)90250-t.
Paroxysmal nocturnal hemoglobinuria is an acquired hematopoietic disease characterized by abnormal blood cell populations in which the biosynthesis of the glycosylphosphatidylinositol (GPI) anchor is deficient. Deficiency of surface expressions of GPI-anchored complement inhibitors leads to complement-mediated hemolysis. Here we report that PIG-A, which participates in the early step of GPI anchor biosynthesis, is the gene responsible for paroxysmal nocturnal hemoglobinuria. Affected granulocytes and B lymphocytes had the same somatic mutation of PIG-A, indicating their clonal origin from a multipotential hematopoietic stem cell. We localized PIG-A to the X chromosome, which accounts for expression of the recessive phenotype of the somatic mutation and the fact that the same one of the multiple biosynthetic steps is affected in all patients so far characterized.
阵发性夜间血红蛋白尿是一种获得性造血疾病,其特征是血细胞群体异常,糖基磷脂酰肌醇(GPI)锚的生物合成存在缺陷。GPI锚定补体抑制剂的表面表达缺陷会导致补体介导的溶血。在此我们报告,参与GPI锚生物合成早期步骤的PIG-A基因是导致阵发性夜间血红蛋白尿的基因。受影响的粒细胞和B淋巴细胞具有相同的PIG-A体细胞突变,表明它们起源于多能造血干细胞的克隆。我们将PIG-A基因定位到X染色体上,这解释了体细胞突变隐性表型的表达,以及在目前已确诊的所有患者中多个生物合成步骤中的同一个步骤受到影响的事实。